Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rhinoconjunctivitis”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Testing effectiveness (Phase 2)Study completedNCT02156791
What this trial is testing

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

Who this might be right for
Hay Fever
BioTech Tools S.A. 61
Post-approval studies (Phase 4)Looking for participantsNCT06778213
What this trial is testing

Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study

Who this might be right for
Allergic Rhinoconjunctivitis
Wroclaw Medical University 67
Testing effectiveness (Phase 2)Study completedNCT02166268
What this trial is testing

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber

Who this might be right for
Grass Pollen Induced Allergic Rhinoconjunctivitis
ALK-Abelló A/S 140
Not applicableStudy completedNCT02844842
What this trial is testing

Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Who this might be right for
Allergic RhinitisRhinoconjunctivitisAsthma
Roxall Medicina España S.A 152
Large-scale testing (Phase 3)Study completedNCT05668390
What this trial is testing

Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma

Who this might be right for
Allergic RhinoconjunctivitisBirch Pollen Allergy
Stallergenes Greer 553
Large-scale testing (Phase 3)Study completedNCT00135642
What this trial is testing

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

Who this might be right for
Rhinitis, Allergic, Seasonal
Imperial College London 44
Testing effectiveness (Phase 2)Study completedNCT00841516
What this trial is testing

Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative

Who this might be right for
Allergic Rhinoconjunctivitis
Allergopharma GmbH & Co. KG 14
Not applicableStudy completedNCT03963947
What this trial is testing

Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites

Who this might be right for
Rhinoconjunctivitis With or Without Allergic Asthma
Alfons Malet i Casajuana 97
Testing effectiveness (Phase 2)Study completedNCT01438463
What this trial is testing

PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 290
Testing effectiveness (Phase 2)Study completedNCT01506375
What this trial is testing

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Who this might be right for
Hay Fever
BioTech Tools S.A. 24
Large-scale testing (Phase 3)Study completedNCT00803244
What this trial is testing

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Who this might be right for
Primary Disease
Stallergenes Greer 381
Testing effectiveness (Phase 2)Study completedNCT02161107
What this trial is testing

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

Who this might be right for
Seasonal Allergic RhinitisAsthma
Circassia Limited 54
Testing effectiveness (Phase 2)Study completedNCT00987909
What this trial is testing

Exposure Chamber Trial With Cat Immunotherapy

Who this might be right for
Cat Allergy
ALK-Abelló A/S 60
Testing effectiveness (Phase 2)Study completedNCT01466465
What this trial is testing

Vitamin D and Grass Pollen Specific Immunotherapy

Who this might be right for
Allergic Rhinoconjunctivitis
Charite University, Berlin, Germany 35
Large-scale testing (Phase 3)Study completedNCT00408616
What this trial is testing

Efficacy and Safety of Grazax in Children

Who this might be right for
Allergy
ALK-Abelló A/S 253
Large-scale testing (Phase 3)Study completedNCT00264459
What this trial is testing

Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture

Who this might be right for
Grass Pollen Allergy
Allergopharma GmbH & Co. KG 160
Testing effectiveness (Phase 2)Study completedNCT01682070
What this trial is testing

SUBLIVAC FIX Phleum Pratense DT/DRF

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 266
Not applicableStudy completedNCT01535118
What this trial is testing

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)

Who this might be right for
Allergic Rhinoconjunctivitis
ALK-Abelló A/S 2,765
Testing effectiveness (Phase 2)Study completedNCT02311413
What this trial is testing

Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy

Who this might be right for
Cat AllergyCat Hypersensitivity
National Institute of Allergy and Infectious Diseases (NIAID) 39
Testing effectiveness (Phase 2)Study completedNCT01198613
What this trial is testing

ToleroMune Ragweed Exposure Chamber Study

Who this might be right for
Ragweed Allergy
Circassia Limited 275
Load More Results